141 related articles for article (PubMed ID: 24782376)
21. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
22. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
23. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
[TBL] [Abstract][Full Text] [Related]
24. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
26. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
27. Macroprolactinemia: new insights in hyperprolactinemia.
Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
[TBL] [Abstract][Full Text] [Related]
28. Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin.
Aisaka K; Tsuchiya F; Sueta M; Itabashi K; Nose S; Hasegawa A; Obata S; Hiraike H; Yokoyama T
Endocr J; 2018 Feb; 65(2):203-211. PubMed ID: 29162783
[TBL] [Abstract][Full Text] [Related]
29. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
Tütüncüler F; Darendeliler F; Aygün M; Hekim N
Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
[TBL] [Abstract][Full Text] [Related]
30. A new criteria for screening macroprolactinemia using polyethylene glycol treatment combined with different assays for prolactin.
Chen YJ; Song GZ; Wang ZN
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1788-94. PubMed ID: 27212171
[TBL] [Abstract][Full Text] [Related]
31. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
[TBL] [Abstract][Full Text] [Related]
32. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
[TBL] [Abstract][Full Text] [Related]
33. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
[TBL] [Abstract][Full Text] [Related]
35. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
36. [Macroprolactin as etiology of hyperprolactinemia. Method for detection and clinical characterization of the entity in 39 patients].
García Menéndez L; Díez Hernández A; Ciriza de los Ríos C; Delgado Gómez M; Orejas García A; Fernández Erales AL; González Mateo C; Fernández Fernández M
Rev Clin Esp; 2003 Oct; 203(10):459-64. PubMed ID: 14563236
[TBL] [Abstract][Full Text] [Related]
37. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
38. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000.
Rivero A; Alonso E; Grijalba A
Clin Chem Lab Med; 2004 May; 42(5):566-8. PubMed ID: 15202797
[No Abstract] [Full Text] [Related]
39. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
McCudden CR; Sharpless JL; Grenache DG
Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
